📌 Frankincense: how AKBA reduces tumor cell proliferation according to new clinical studies
Posted 4 February 2026 by: Admin
Boswellia frankincense is increasingly interesting to scientific research for its active compounds, notably AKBA (acetyl-11-keto-β-boswellic acid). Laboratory studies and a phase Ia clinical trial have observed a significant reduction in tumor cell proliferation in breast cancer patients. How does this ancestral resin act on cellular pathways, and what do the latest clinical data reveal about its tolerance and potential?
Advertisement:
While medical research relentlessly explores new…
Advertisement:
Read the full article..
Advertisement:










